Cidara Therapeutics, Inc

About Cidara Therapeutics, Inc

Cidara Therapeutics (“Cidara”) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives that have the potential to transform the standard of care and save or improve patients’ lives. Our lead product candidate is CD101 IV, a novel echinocandin therapy being developed for the treatment and prevention of systemic fungal infections. In addition, we have developed a proprietary immunotherapy technology platform, Cloudbreak™, designed specifically to create compounds that direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease.

San Diego, CA
We're Hiring!

More about Cidara Therapeutics, Inc